Dopamine is necessary to endogenous morphine formation in mammalian brain in vivo

Journal of Neurochemistry

Volumn 106, Issue 6, 2008, Pages 2337-2344

  Neri, Carla ^a   Ghelardini, Carla ^b   Sotak, Bethany ^c   Palmiter, Richard D ^c   Guarna, Massimo ^d   Stefano, George ^e   Bianchi, Enrica ^d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SIENA   (Italy)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

Biosynthetic pathway; Dopamine; Morphine; Transgenic mouse

Indexed keywords

DOPAMINE; MORPHINE; TYROSINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; GENE DELETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; WILD TYPE;

ANIMALS; BODY TEMPERATURE REGULATION; BRAIN; DOPAMINE; MICE; MICE, KNOCKOUT; MORPHINE; OPIOID PEPTIDES; SENSORY THRESHOLDS; TEMPERATURE SENSE; TYROSINE; TYROSINE 3-MONOOXYGENASE;

MAMMALIA; MUS; MUS MUSCULUS; RODENTIA;

EID: 50849090581     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05572.x     Document Type: Article

References (41)

1. Bianchi E., Alessandrini C., Guarna M. Tagliamonte A. (1993) Endogenous codeine and morphine are stored in specific brain neurons. Brain Res. 627, 210 215.
2. Bianchi E., Guarna M. Tagliamonte A. (1994) Endogenous codeine and morphine are stored in specific brain neurons. Adv. Neuroimmunol. 4, 83 92.
3. Boettcher C., Fellermeier M., Boettcher C., Drager B. Zenk M. H. (2005) How human neuroblastoma cells make morphine. Proc. Natl Acad. Sci. USA 102, 8495 8500.
4. Cardinale G. J., Donnerer J., Finck A. D., Kantrowitz J. D., Oka K. Spector S. (1987) Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sci. 40, 301 306.
5. Chourbaji S., Hellweg R., Brandis D., Zörner B., Zacher C., Lang U. E., Henn F. A., Hörtnagl H. Gass P. (2004) Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res. Mol. Brain Res. 121, 28 36.
6. Don-Liang L., Hwang L. Chau-Yang C. (1995) Storage temperature effect on the stability of morphine and codeine in urine. J. Anal. Toxicol. 19, 275 280.
7. Donnerer J., Oka K., Brossi A., Rice K. C. Spector S. (1986) Presence and formation of codeine and morphine in the rat. Proc. Natl Acad. Sci. USA 83, 4566 4567.
8. Donnerer J., Cardinale G., Coffey J., Lisek C. A., Jardine I. Spector S. (1987) Chemical characterization and regulation of endogenous morphine and codeine in the rat. J. Pharmacol. Exp. Ther. 242, 583 587.
9. Felby S., Christensen H. Lund A. (1974) Morphine concentration in blood and organ in case of fatal poisoning. Forensic Sci. 3, 77 81.
10. Gintzler A. R., Levy A. Spector S. (1976) Antibodies as a means of isolating and characterizing biologically active substances: presence of a non peptide morphine like compound in central nervous system. Proc. Natl Acad. Sci. USA 73, 2132 2136.
11. Gintzler A. R., Gershon M. D. Spector S. A. (1978) A nonpeptide morphine-like compound: immunocytochemical localization in the mouse brain. Science 199, 447 448.
12. Goldstein A., Barrett R. W., James I. F., Lowney L. I., Weitz C. J., Knipmeyer L. L. Rapoport H. (1985) Morphine and other opiates from beef brain and adrenals. Proc. Natl Acad. Sci. USA 82, 5203 5207.
13. Goumon Y. Stefano G. B. (2000) Identification of morphine in the rat adrenal gland. Brain Res. Mol. Brain Res. 77, 267 269.
14. Guarna M., Neri C., Petrioli F. Bianchi E. (1998) Potassium-induced release of endogenous morphine from rat brain slices. J. Neurochem. 70, 147 152.
15. Guarna M., Bianchi E., Bartolini A., Ghelardini C., Galeotti N., Bracci L., Neri C., Sonetti D. Stefano G. (2002) Endogenous morphine modulates acute thermonociception in mice. J. Neurochem. 80, 271 277.
16. Guarna M., Ghelardini C., Galeotti N., Bartolini A., Noli L., Neri C., Stefano G. B. Bianchi E. (2004) Effects of endogenous morphine deprivation zon memory retention of passive avoidance learning in mice. Int. J. Neuropsychopharmacol. 7, 311 319.
17. Guevara-Guzman R., Emson P. C. Kendrick K. M. (1994) Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 62, 807 810.
18. Hazum E., Sabatka J. J., Chang K. J., Brent D. A., Findlay J. W. Cuatrecasas P. (1981) Morphine in cow and human milk: could dietary morphine constitute a ligand for specific morphine (mu) receptors? Science 213, 1010 1012.
19. Hnasko T. S., Sotak B. N. Palmiter R. D. (2005) Morphine reward in dopamine-deficient mice. Nature 438, 854 857.
20. Hofmann U., Seefried S., Schweizer E., Ebner T., Mikus G. Eichelbaum M. (1999) Highly sensitive gas chromatographic-tandem mass spectrometric method for the determination of morphine and codeine in serum and urine in the femtomolarrange. J. Chromatogr. Biomed. Sci. Appl. 727, 81 88.
21. Killian A. K., Schuster C. R., House J. T., Sholl S., Connors M. Wainer B. H. (1981) A non-peptide morphinelike compound from brain. Life Sci. 28, 811 817.
22. Kodaira H. Spector S. (1988) Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes. Proc. Natl Acad. Sci. USA 85, 1267 1271.
23. Kodaira H., Lisek C. A., Jardine I., Arimura A. Spector S. (1989) Identification of the convulsant opiate thebaine in mammalian brain. Proc. Natl Acad. Sci. USA 86, 716 719.
24. Kutchan T. N. (1998) Molecular genetics of plant alkaloid biosynthesis, in The Alkaloids, vol 50 (Cordell G., ed.), pp. 257 316. AcademicPress, San Diego.
25. Lee C. S. Spector S. (1991) Changes of endogenous morphine and codeine contents in the fasting rat. J. Pharmacol. Exp. Ther. 257, 647 650.
26. Liu Y., Bilfinger T. V. Stefano G. B. (1997) A rapid and sensitive quantitation method of endogenous morphine in human plasma. Life Sci. 60, 237 243.
27. Lubli G., Neri C. Chiminazzo S. (1990) Solid phase extraction of whole blood samples for general unknown investigations, in Proceedings of the 27th International Meeting of the International Association of Forensic Toxicologists (Marigo, ed pp. 258 274. International Association of Forensic Toxicologists, Perth, Australia.
28. Matsubara K., Fukushima S., Akane A., Kobayashi S. Shiono H. (1992) Increased urinary morphine, codeine and tetrahydropapaveroline in parkinsonian patient undergoing L-3,4-dihydroxyphenylalanine therapy: a possible biosynthetic pathway of morphine from L-3,4-dihydroxyphenylalanine in humans. Pharmacol. Exp. Ther. 260, 974 978.
29. Muller A., Glattard E., Taleb O. et al. (2008) Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PLoS ONE.e1641 3, 1 13.
30. Nelson T. E., King J. S. Bishop G. A. (1997) Distribution of tyrosine hydroxylase-immunoreactive afferents to the cerebellum differs between species. J. Comp. Neurol. 379, 443 454.
31. Neri C., Guarna M., Bianchi E., Sonetti D., Matteucci G. Stefano G. B. (2004) Endogenous morphine and codeine in the brain of non human primate. Med. Sci. Monit. 10, 1 5.
32. Pfleger K., Maurer H. H. Weber A. (1992) Mass spectral and GC data of drugs, poisons, pesticides, in Pollutants and Their Metabolites (Weber, ed pp. 1784 1785. WHC, Weinheim.
33. Poeaknapo C., Schmidt J., Brandsch M., Drager B. Zenk M. H. (2004) Endogenous formation of morphine in human cells. Proc. Natl Acad. Sci. USA 101, 14091 14096.
34. Seroogy K. B., Dangaran K., Lim S., Haycock J. W. Fallon J. H. (1989) Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions. J. Comp. Neurol. 279, 397 414.
35. Slaoui T., Mas-Gerdelat A., Ory-Magne F., Rascol O. Brefel-Courbon C. (2007) Levodopa modifies pain thresholds in Parkinson's disease patients. Rev. Neurol. (Paris) 163, 66 71.
36. Stefano G. B., Digenis A., Spector S., Leung M. K., Bilfinger T. V., Makman M. H., Scharrer B. Abumrad N. N. (1993) Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc. Natl Acad. Sci. USA 90, 11099 11103.
37. Szczypka M. S., Rainey M. A., Kim D. S., Alaynick W. A., Marck B. T., Matsumoto A. M. Palmiter R. D. (1999) Feeding behavior in dopamine-deficient mice. Proc. Natl Acad. Sci. USA 96, 12138 12143.
38. Zhou Q. Y. Palmiter R. D. (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell. 83, 1197 1209.
39. Zhu W., Ma Y., Cadet P., Yu D., Bilfinger T. V., Bianchi E. Stefano G. B. (2003) Presence of reticuline in rat brain: a pathway for morphine biosynthesis. Brain Res. Mol. Brain Res. 117, 83 90.
40. Zhu W., Ma Y., Bell A., Esch T., Guarna M., Bilfinger T. V., Bianchi E. Stefano G. B. (2004) Presence of morphine in rat amygdala: evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med. Sci. Monit. 10, 433 439.
41. Zhu W., Cadet P., Baggerman G., Mantione K. J. Stefano G. B. (2005) Human white blood cells synthesize morphine: CYP2D6 modulation. J. Immunol. 175, 7357 7362.